Cargando…
A “Wait-and-See” Approach to Quiescent Single-System Langerhans Cell Histiocytosis to Spare Children From Chemotherapy
Background: Langerhans Cell Histiocytosis (LCH) is a childhood disorder of histiocytes that is generally treated with systemic chemotherapy. Spontaneous resolution has been previously reported in Single System LCH (SS-LCH), which is less aggressive than multisystem disease. However, there are no cle...
Autores principales: | Oh, Bernice, Lee, Shawn, Ke, Yuhe, Kimpo, Miriam, Yeoh, Allen, Quah, Thuan Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434943/ https://www.ncbi.nlm.nih.gov/pubmed/32903429 http://dx.doi.org/10.3389/fped.2020.00466 |
Ejemplares similares
-
BRAF V600E-Positive Congenital Multisite Langerhans Cell Histiocytosis
por: Prada Avella, Maria Camila, et al.
Publicado: (2020) -
Case Report: Two Infant Cases of Langerhans Cell Histiocytosis Involving the Digestive Tract
por: Wang, Huan, et al.
Publicado: (2021) -
Case report: “Congenital cutaneous langerhans cell histiocytosis presenting with blueberry Muffin Rash”
por: Thalji, Mariam, et al.
Publicado: (2022) -
BRAF Mutation Analysis in Two Cases of Congenital Self-Healing Langerhans Cell Histiocytosis
por: Takayama, Saki, et al.
Publicado: (2022) -
The Role of Natural Killer Cells as a Platform for Immunotherapy in Pediatric Cancers
por: Kimpo, Miriam Santiago, et al.
Publicado: (2019)